Donor leukocyte infusions for multiple myeloma (Q73375198)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11149728%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Donor leukocyte infusions for multiple myeloma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11149728%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

7

Porter D

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11149728%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

Salama M

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11149728%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Nevill T

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11149728%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Marcellus D

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11149728%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Parker P

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11149728%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Johnson M

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11149728%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Kirk A

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11149728%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Giralt S

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11149728%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Levine JE

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11149728%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Drobyski W

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11149728%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Barrett AJ

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11149728%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Horowitz M

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11149728%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Collins RH

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11149728%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 December 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11149728%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11149728%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11149728%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11149728%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

1179-1184

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11149728%20AND%20SRC:MED&resulttype=core&format=json

Treatment of murine leukaemia with X rays and homologous bone marrow; preliminary communication.

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702685

7 January 2021

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702685

7 January 2021

How does bone-marrow transplantation cure leukaemia?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702685

7 January 2021

Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702685

7 January 2021

Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702685

7 January 2021

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702685

7 January 2021

Graft-versus-myeloma effect in two cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702685

7 January 2021

Graft-versus-myeloma effect

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702685

7 January 2021

Adoptive immunotherapy for relapsed multiple myeloma after allogeneic bone marrow transplantation (BMT): evidence for a graft-versus-myeloma effect

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702685

7 January 2021

Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702685

7 January 2021

Graft-versus-myeloma after donor leukocyte infusion: maintenance of marrow remission but extramedullary relapse with plasmacytomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702685

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702685

1 reference

7 January 2021

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702685

7 January 2021

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702685

7 January 2021

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702685

7 January 2021